STRATEGY: Stick with Epicenter in 2H2021. Strong markets stay strong. US COVID-19 deaths are “unvaccinated” Americans COVID-19 cases could be rising, in part due to the spread of the more transmissible variants (Delta, etc.), but the approved vaccines seem to be containing the spread, and more importantly, limiting the severity of the disease (for a vaccinated individual). The AP published…
Energy positive returns 6 consecutive months. Stick with Epicenter in 2H2021.
A financial market resource for the every-day investor and trader.
-
Be Careful With A Long VIX Strategy
Seth Golden, , Research Reports, 0
Three trading weeks have been logged in the New Year and with that… still no signs of increasing volatility...
-
Quarterly Update For Golden Capital Portfolio: Tesla Remains In Focus After Quick Profits
Seth Golden, , Research Reports, 0
Golden Capital Portfolio continues to outperform the benchmark S&P 500 Return On Invested Capital year-to-date. In my most recent...
-
Weekly Warm-up: Operating Leverage Cuts Both Ways as Inflation Peak Signals Margin Risk
Seth Golden, , Research Reports, 0
The rise in inflation and the Fed’s reaction to it has been a real headwind for valuations this year....
-
Marko Kolanovic/J.P. Morgan 2020 Outlook
Seth Golden, , Research Reports, 0
MACROECONOMIC OUTLOOK: Our view is that the market turmoil and economic slowdown over the past 18 months is not...
-
Pivotal Point For Market Trend Lay Ahead: Review Your Process
Seth Golden, , Research Reports, 0
Everyday I read The Chart Report. It’s a mixture of charts and thoughtful quotes for what I find to...
-
3Fourteen Research: The Path to a Pivot
Seth Golden, , Research Reports, 0
Approaching the end of the year, it is natural to wonder: What lies ahead? Where does this road lead?...
-
-
Weekly State of the Market: Diagnosing Drawdown For Opportunity
Seth Golden, , Research Reports, 0
“We have to acknowledge that overall breadth is weaker than it was during the biggest market drawdown during Q1...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00